JAK Inhibition May Improve Multiple Autoimmune Conditions in People with Down Syndrome
Janus kinase (JAK) inhibition may decrease the burden of autoimmune conditions in people with Down syndrome, according to a new study published in eLife. Drawing upon their 2016 discovery that the interferon response is constantly activated in people with Down syndrome, researchers designed the trial to focus on the autoimmune and inflammatory skin conditions that are common […]